AsiaTIDES 
Event Information
|
Oligonucleotide and Peptide ® Technology and Product Development Conference
February 23 - 25, 2009 Sheraton Miyako Hotel · Tokyo, Japan |
Alternate Language Options:
|
Document Title
Scientific Advisory Committee
- Jesse Dong, Ph.D., Senior Director, Medicinal Chemistry, IPSEN/Biomeasure, Incorporated, USA
- Takefumi Gemba, Ph.D., Member of the Board, Corporate Officer & Vice President, Pharmaceutical Research, AnGes MG, Inc., Japan
- Kazuko Hirabayashi, Ph.D., General Manager, Division of Nucleic Acids Business Research and Development, Nippon Shinyaku Co., Ltd., Japan
- Venkat R. Kalavakolanu, Chairman & Managing Director, Jupiter Bioscience Limited, India
- David Konys, Vice President, Manufacturing Operations, Alnylam Pharmaceuticals, USA
- Shawn Lee, Ph.D., President and CEO, CPC Scientific, USA and China
- Yoshikazu Nakamura, Ph.D., Professor, Department of Basic Medical Science, Institute of Medical Science, University of Tokyo; Founder, Ribomic, Japan
- Kal Reddy, Ph.D., Development Manager, Agilent Technologies, USA
- Thomas Rupp, Bioprocess Customer Application Support Oligonucleotides, GE Healthcare BioProcess, Germany
- Yogesh Sanghvi, Ph.D., President, Rasayan Inc., USA
- Hideaki Sato, General Manager, Technical Support & Marketing Division, GeneDesign, Inc., Japan
- Hiroshi Shiragami, Ph.D., General Manager, Intermediate Chemicals Department, Ajinomoto, Japan
- G. Susan Srivatsa, Ph.D., President, ElixinPharma, USA
- Akira Yamada, Ph.D., Professor, Cancer Vaccine Development Division, Kurume University Research Center for Innovative Cancer Therapy, Japan
Bottom menu
Copyright IBC Life Sciences, a part of Informa Life Sciences Group